News

All-cause mortality is 50% more likely during this common diabetes complication SOMERVILLE, Mass., January 18, 2022 —  Podimetrics, a virtual care support company dedicated to preventing costly and deadly diabetic amputations, today announced results from its latest research, which compared the health of individuals during and after periods of diabetic foot ulceration — open sores […]

Every 4 minutes in the U.S., a patient loses a limb due to diabetes complications  Black Americans face diabetes-related amputations 2x as often as white Americans Podimetrics strives to reduce disparities in diabetes care and unnecessary limb loss SOMERVILLE, Mass., March 24, 2022 — Podimetrics, creator of the FDA-cleared SmartMat™ and integrated clinical care services

Longtime Congresswoman and former President and CEO of the Better Medicare Alliance, Allyson Schwartz, also joins Podimetrics’ Advisory Board SOMERVILLE, Mass., May 12, 2022 — Podimetrics Inc, creator of the FDA-cleared SmartMat™ and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes, today announced four new leadership

OAKLAND, Calif., Oct. 24, 2022–Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric solutions, presented two newly published clinical studies for the treatment of lymphedema and venous disease with its Dayspring® active compression system that showed significant improvements in patient outcomes. Stanley Rockson,

By Using Mind.Px, Patients Achieve PASI75 Faster than Treatment-as-Usual Cohort SAN DIEGO, CA – October 20, 2022 – Interim clinical utility and patient outcomes data regarding Mindera Health’s Mind.Px™ test from the ongoing MATCH study were recently presented at the Fall Clinical Dermatology Conference 2022 in Las Vegas, one of the largest US-based dermatology educational

Eirion Therapeutics Announces Initiation of First-in-Human Clinical Trial Evaluating Next Generation, Ready-to-Use Liquid Injectable Neuromodulator AI-09 for the Treatment of Wrinkles Company Also Announces Update for Its Lead, Phase 2b Product Candidate Topical Neuromodulator ET-01 Oct 17, 2022 – Woburn, MA Eirion Therapeutics Inc. announced today that the first participants have been dosed in a

OAKLAND, Calif., Oct. 4, 2022 —Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced two clinical data publications for the treatment of lymphedema and venous disease with its Dayspring® active compression system, including results from the multi-center, randomized, crossover head-to-head

San Carlos, Calif. (October 6, 2022) – Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life, will highlight its LimiFlex™ Dynamic Sagittal Tether™ (DST) at the North American Spine Society (NASS)

Channel Medsystems Announces First Endometrial Ablation Procedures in Europe with the Cerene® Cryotherapy Device BERKELEY, Calif., DATE – Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first procedures in Europe were performed with the Cerene® Cryotherapy Device for

MENLO PARK, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives today announced Clinical Ophthalmology has published data from a subgroup analysis of the OLYMPIA trial, which showed a single treatment with the TearCare System